Literature DB >> 24687274

Association between serum soluble low-density lipoprotein receptor levels and metabolic factors in healthy Japanese individuals.

Hisashi Shimohiro1, Shin-Ichi Taniguchi, Masahiko Koda, Chieko Sakai, Sadako Yamada.   

Abstract

BACKGROUND: Soluble low-density lipoprotein receptor (sLDL-R) is formed by cleavage of the extracellular domain of low-density lipoprotein receptor (LDL-R). It is unclear whether serum sLDL-R is a marker of diseases associated with triglyceride (TG) metabolism. We investigated the association between serum sLDL-R concentrations and other biochemical parameters in healthy Japanese individuals.
METHODS: Study subjects consisted of 102 healthy adult Japanese volunteers (42 men, 60 women) with body mass index (BMI) < 30 kg/m(2) and serum TGs, LDL cholesterol (LDL-C), aspartate aminotransferase, alanine aminotransferase, γ-glutamyl transpeptidase, and glucose concentrations within normal ranges. Serum sLDL-R concentrations were determined by enzyme-linked immunosorbent assay and their correlations with biochemical parameters were analyzed.
RESULTS: Mean serum sLDL-R concentration was 120.9 ± 39.9 ng/ml. Serum sLDL-R levels were significantly and positively correlated with BMI (rs = 0.252) and TG (rs = 0.408) and LDL-C (rs = 0.325) concentrations. Multiple regression analysis adjusted for age, gender, and smoking showed that BMI (β = 0.274), TG (β = 0.328), and LDL-C (β = 0.224) were factors independently correlated with sLDL-R levels.
CONCLUSION: Serum sLDL-R concentration may be a marker of diseases associated with TG metabolism. This is the first report to date describing the clinical relevance of sLDL-R.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ADAM17; ELISA; TG metabolism; ectodomain shedding; sLDL-R

Mesh:

Substances:

Year:  2014        PMID: 24687274      PMCID: PMC6807053          DOI: 10.1002/jcla.21727

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  19 in total

1.  ELISA measurement of LDL receptors.

Authors:  K May; F B Kraemer; J Chen; A D Cooper
Journal:  J Lipid Res       Date:  1990-09       Impact factor: 5.922

2.  Obesity and NASH in Japan.

Authors:  Toshiki Komeda
Journal:  Hepatol Res       Date:  2005-10-10       Impact factor: 4.288

3.  The type 2 diabetes and insulin-resistance locus near IRS1 is a determinant of HDL cholesterol and triglycerides levels among diabetic subjects.

Authors:  Rajani Sharma; Sabrina Prudente; Francesco Andreozzi; Christine Powers; Gaia Mannino; Simonetta Bacci; Ernest V Gervino; Thomas H Hauser; Elena Succurro; Luana Mercuri; Elizabeth H Goheen; Hetal Shah; Vincenzo Trischitta; Giorgio Sesti; Alessandro Doria
Journal:  Atherosclerosis       Date:  2011-01-26       Impact factor: 5.162

4.  The cytoplasmic domains of TNFalpha-converting enzyme (TACE/ADAM17) and L-selectin are regulated differently by p38 MAPK and PKC to promote ectodomain shedding.

Authors:  David J Killock; Aleksandar Ivetić
Journal:  Biochem J       Date:  2010-05-13       Impact factor: 3.857

Review 5.  Pharmacological regulation of low density lipoprotein receptor expression: current status and future developments.

Authors:  Marc Issandou
Journal:  Pharmacol Ther       Date:  2006-01-19       Impact factor: 12.310

6.  Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study.

Authors:  Yuichiro Eguchi; Hideyuki Hyogo; Masafumi Ono; Toshihiko Mizuta; Naofumi Ono; Kazuma Fujimoto; Kazuaki Chayama; Toshiji Saibara
Journal:  J Gastroenterol       Date:  2012-02-11       Impact factor: 7.527

Review 7.  The role of ADAM17 in metabolic inflammation.

Authors:  Rossella Menghini; Loredana Fiorentino; Viviana Casagrande; Renato Lauro; Massimo Federici
Journal:  Atherosclerosis       Date:  2013-01-25       Impact factor: 5.162

Review 8.  The LDL receptor.

Authors:  Joseph L Goldstein; Michael S Brown
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04       Impact factor: 8.311

9.  Mutation in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains.

Authors:  M A Lehrman; W J Schneider; T C Südhof; M S Brown; J L Goldstein; D W Russell
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

Review 10.  Non-alcoholic fatty liver disease and the metabolic syndrome: an update.

Authors:  R Scott Rector; John P Thyfault; Yongzhong Wei; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

View more
  5 in total

1.  Relationship between XspI Site Polymorphisms of LDL-R Gene and Serum IL-2 and IL-10 in Patients with Hypercholesterolemia.

Authors:  Mingming Zhang; Yamin Lu; Xin Liu; Xiaobin Zhang; Cuigai Zhang; Wei Gao; Yanqing Tie
Journal:  J Clin Lab Anal       Date:  2016-04-28       Impact factor: 2.352

2.  The enigma of soluble LDLR: could inflammation be the key?

Authors:  Majambu Mbikay; Janice Mayne; Michel Chrétien
Journal:  Lipids Health Dis       Date:  2020-02-03       Impact factor: 3.876

3.  Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis.

Authors:  Adekunle Alabi; Xiao-Dan Xia; Hong-Mei Gu; Faqi Wang; Shi-Jun Deng; Nana Yang; Ayinuer Adijiang; Donna N Douglas; Norman M Kneteman; Yazhuo Xue; Li Chen; Shucun Qin; Guiqing Wang; Da-Wei Zhang
Journal:  Nat Commun       Date:  2021-03-25       Impact factor: 14.919

4.  Identification of amino acid residues in the MT-loop of MT1-MMP critical for its ability to cleave low-density lipoprotein receptor.

Authors:  Maggie Wang; Adekunle Alabi; Hong-Mei Gu; Govind Gill; Ziyang Zhang; Suha Jarad; Xiao-Dan Xia; Yishi Shen; Gui-Qing Wang; Da-Wei Zhang
Journal:  Front Cardiovasc Med       Date:  2022-08-25

Review 5.  Membrane-type I matrix metalloproteinase (MT1-MMP), lipid metabolism, and therapeutic implications.

Authors:  Xiao-Dan Xia; Adekunle Alabi; Maggie Wang; Hong-Mei Gu; Rui Zhe Yang; Gui-Qing Wang; Da-Wei Zhang
Journal:  J Mol Cell Biol       Date:  2021-10-21       Impact factor: 6.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.